Funding for this research was provided by:
National Health and Medical Research Council (614247)
Received: 1 December 2017
Accepted: 18 April 2018
First Online: 2 May 2018
Ethics approval and consent to participate
: The study was approved by Human Research Ethics Committees at all sites: Alfred Hospital Ethics Committee (Victoria lead), Hunter New England Human Research Ethics Committee (NSW lead), Mater Health Services Human Research Ethics Committee, Southern Adelaide Clinical Research Ethics Committee, St. Vincent’s Health & Aged Care, Queensland University of Technology. All participants signed an approved Patient Information and Consent Form.
: All authors report the NHMRC Grant Funding. JH declares participation in medical advisory boards of MundiPharma Pty Ltd. and Menarini Ltd. Australia. OS declares advisory board consulting fees for Teva Pharmaceutical.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.